(Q43670410)

English

Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less

scientific article published on 2 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Kastunori Imai

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Toru Beppu

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Akira Chikamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Koichi Doi

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hirohisa Okabe

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hiromitsu Hayashi

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hidetoshi Nitta

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Takatoshi Ishiko

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hiroshi Takamori

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hideo Baba

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

2 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

853-864

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Early hepatocellular carcinoma: pathology, imaging, and therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12035

21 January 2018

Identifiers

10.1111/HEPR.12035

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43670410&oldid=2102411268"